<DOC>
	<DOC>NCT02592447</DOC>
	<brief_summary>The purpose of this study is to evaluate Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) with fatigued chronic myelogenous leukemia (CML) patients on tyrosine kinase inhibitors (TKIs) for feasibility, acceptability and potential efficacy relative to usual care only in a small-scale randomized controlled trial.</brief_summary>
	<brief_title>Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention</brief_title>
	<detailed_description />
	<mesh_term>Leukemia, Myeloid</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Leukemia, Myelogenous, Chronic, BCR-ABL Positive</mesh_term>
	<criteria>able to speak/read English diagnosed with chronic phase CML not have been treated for other cancer (except nonmelanoma skin cancer) in the past 5 years be under the care of a Moffitt Cancer Center (MCC) physician be on a stable dose of the same oral TKI for &gt;= 3 months new onset or worsening of fatigue since starting TKI report moderatesevere fatigue in past week (FSI average rating &gt;= 4 of 010) have no clinical history of disease (e.g., multiple sclerosis, fibromyalgia) that could account for their fatigue presentation scheduled to discontinue their TKI under medical supervision within the next 3 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>CML</keyword>
	<keyword>chronic phase CML</keyword>
	<keyword>leukemia</keyword>
</DOC>